Trade Elekta B - EKTAb CFD
Add to favourite- Summary
- Historical Data
Spread | 0.40 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.021243% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000979% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | SEK | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Sweden | ||||||||
Commission on trade | 0% |
Prev. Close | 66.7 |
Open | 66.3 |
1-Year Change | -22.46% |
Day's Range | 66.3 - 67.2 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 66.65 | -0.70 | -1.04% | 67.35 | 67.35 | 66.20 |
Jul 24, 2024 | 67.50 | 1.15 | 1.73% | 66.35 | 67.65 | 66.35 |
Jul 23, 2024 | 66.80 | -0.70 | -1.04% | 67.50 | 67.80 | 66.70 |
Jul 22, 2024 | 67.35 | 1.00 | 1.51% | 66.35 | 68.20 | 66.35 |
Jul 19, 2024 | 66.55 | -1.35 | -1.99% | 67.90 | 67.90 | 66.45 |
Jul 18, 2024 | 67.35 | 0.50 | 0.75% | 66.85 | 68.00 | 66.25 |
Jul 17, 2024 | 66.60 | 0.20 | 0.30% | 66.40 | 66.95 | 65.80 |
Jul 16, 2024 | 66.50 | -0.15 | -0.23% | 66.65 | 66.85 | 65.05 |
Jul 15, 2024 | 66.85 | -0.90 | -1.33% | 67.75 | 68.05 | 66.60 |
Jul 12, 2024 | 67.75 | 1.35 | 2.03% | 66.40 | 67.90 | 66.15 |
Jul 11, 2024 | 66.55 | -0.15 | -0.22% | 66.70 | 66.75 | 65.90 |
Jul 10, 2024 | 66.30 | 1.40 | 2.16% | 64.90 | 67.05 | 64.90 |
Jul 9, 2024 | 65.25 | -1.90 | -2.83% | 67.15 | 67.90 | 65.25 |
Jul 8, 2024 | 67.50 | -0.65 | -0.95% | 68.15 | 68.75 | 66.80 |
Jul 5, 2024 | 68.15 | 1.70 | 2.56% | 66.45 | 68.35 | 66.25 |
Jul 4, 2024 | 66.60 | 0.55 | 0.83% | 66.05 | 66.70 | 65.70 |
Jul 3, 2024 | 66.35 | 1.05 | 1.61% | 65.30 | 66.80 | 64.90 |
Jul 2, 2024 | 65.30 | 0.20 | 0.31% | 65.10 | 65.80 | 64.85 |
Jul 1, 2024 | 65.55 | -0.75 | -1.13% | 66.30 | 67.45 | 65.50 |
Jun 28, 2024 | 66.00 | -0.05 | -0.08% | 66.05 | 66.50 | 65.60 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Elekta Company profile
About Elekta AB (publ)
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
Financial summary
BRIEF: For the nine months ended 31 January 2022, Elekta AB (publ) revenues increased 2% to SEK10.31B. Net income decreased 19% to SEK738M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Europe, Middle East and Africa segment income decrease of 63% to SEK481M, Asia Pacific segment income decrease of 66% to SEK402M.
Equity composition
10/2005, 3-for-1 stock split. 9/2012, 4-for-1 stock split (Factor: 4).
Industry: | Advanced Medical Equipment & Technology (NEC) |
Kungstensgatan 18
STOCKHOLM
STOCKHOLM 113 57
SE
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com